Folgen
Sylvia Villeneuve
Sylvia Villeneuve
Bestätigte E-Mail-Adresse bei mcgill.ca - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Brain charts for the human lifespan
RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ...
Nature 604 (7906), 525-533, 2022
6222022
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
S Villeneuve, GD Rabinovici, BI Cohn-Sheehy, C Madison, N Ayakta, ...
Brain 138 (7), 2020-2033, 2015
3662015
Associations between serum cholesterol levels and cerebral amyloidosis
B Reed, S Villeneuve, W Mack, C DeCarli, HC Chui, W Jagust
JAMA neurology 71 (2), 195-200, 2014
2732014
Mild cognitive impairment in moderate to severe COPD: a preliminary study
S Villeneuve, V Pepin, S Rahayel, JA Bertrand, M de Lorimier, A Rizk, ...
Chest 142 (6), 1516-1523, 2012
2112012
Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people
M Wirth, S Villeneuve, CM Haase, CM Madison, H Oh, SM Landau, ...
JAMA neurology 70 (12), 1512-1519, 2013
1862013
Gene–environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden
M Wirth, S Villeneuve, R La Joie, SM Marks, WJ Jagust
Journal of Neuroscience 34 (25), 8612-8617, 2014
1462014
Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps
N Bhattacharyya, S Villeneuve, VN Joish, C Amand, L Mannent, N Amin, ...
The Laryngoscope 129 (9), 1969-1975, 2019
1412019
Odor identification as a biomarker of preclinical AD in older adults at risk
ME Lafaille-Magnan, J Poirier, P Etienne, J Tremblay-Mercier, J Frenette, ...
Neurology 89 (4), 327-335, 2017
1322017
Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults
M Wirth, CM Haase, S Villeneuve, J Vogel, WJ Jagust
Neurobiology of aging 35 (8), 1873-1882, 2014
1322014
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
PF Meyer, J Tremblay-Mercier, J Leoutsakos, C Madjar, ...
Neurology 92 (18), e2070-e2080, 2019
1262019
Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions
S Villeneuve, BR Reed, CM Madison, M Wirth, NL Marchant, S Kriger, ...
Neurology 83 (1), 40-47, 2014
1112014
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum
WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ...
JAMA neurology 79 (3), 228-243, 2022
1082022
Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors
F Peters, S Villeneuve, S Belleville
Journal of Alzheimer's disease 38 (2), 307-318, 2014
1012014
Association of gray matter atrophy with age, β-amyloid, and cognition in aging
H Oh, C Madison, S Villeneuve, C Markley, WJ Jagust
Cerebral cortex 24 (6), 1609-1618, 2014
1002014
Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI
LL Chao, C DeCarli, S Kriger, D Truran, Y Zhang, J Laxamana, ...
PloS one 8 (6), e65175, 2013
952013
Characterization of Alzheimer disease biomarker discrepancies using cerebrospinal fluid phosphorylated tau and AV1451 positron emission tomography
PF Meyer, AP Binette, J Gonneaud, JCS Breitner, S Villeneuve, ...
JAMA neurology 77 (4), 508-516, 2020
872020
Repetitive negative thinking is associated with amyloid, tau, and cognitive decline
NL Marchant, LR Lovland, R Jones, A Pichet Binette, J Gonneaud, ...
Alzheimer's & Dementia 16 (7), 1054-1064, 2020
802020
Regional correlations between [11C] PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort
SW Seo, N Ayakta, LT Grinberg, S Villeneuve, M Lehmann, B Reed, ...
NeuroImage: Clinical 13, 130-137, 2017
712017
The potential applications of Apolipoprotein E in personalized medicine
S Villeneuve, D Brisson, NL Marchant, D Gaudet
Frontiers in aging neuroscience 6, 154, 2014
702014
Validity of the Mattis Dementia Rating Scale to detect mild cognitive impairment in Parkinson’s disease and REM sleep behavior disorder
S Villeneuve, J Rodrigues-Brazète, S Joncas, RB Postuma, V Latreille, ...
Dementia and geriatric cognitive disorders 31 (3), 210-217, 2011
682011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20